Aprovix is a medical technology company with its registered office at Gårdsvägen 8, Solna, Sweden. Aprovix was founded in 2001 by Professor Erik Wilander at Uppsala University Hospital, Sweden.

SVEN MATTSSON, CEO AND CHAIRMAN OF THE BOARD

Unique blend of broad-based international operational experience in general management; sales, marketing, business development, and strategic planning. Innovative self-starter, builds consensus for company goals and approaches each new challenge with a contagious desire for success. Strengths include high energy level, leadership, vision and a commitment to a quality performance. Extended experience of restructuring, buy-outs and IPO's.

ERIK WILANDER, FOUNDER and Medical Director

Professor Erik Wilander holds certifications as MD; with specialist certifications in Clinical Cytology and Surgical Pathology. Between 1985 and 2010 Erik was Chairman of the Department of Clinical Cytology at Uppsala University Hospital. Professor in clinical pathology from 2001. He has authored 280+ publications in scientific journals; mainly in endocrine pathology, clinical cytology, cervical cancer and HPV related diseases. Erik was first to use at-home self–sampling for HPV screening with dry samples and is the inventor of Qvintip®.

Tatiana erhan, head of quality Assurance and regulatory approval

Tatiana is a regulatory expert in pharmaceuticals and medical devices. In addition to extensive knowledge of quality assurance and regulatory issues, she also has 10+ years of experience in business development and research.